{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:19:45Z","timestamp":1785395985020,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jnma.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T01:26:57Z","timestamp":1663982817000},"page":"589-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic thrombolysis for acute central retinal artery occlusion in sickle cell disease: Case report"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-5225","authenticated-orcid":false,"given":"Estevana","family":"Isaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-416X","authenticated-orcid":false,"given":"Ali A.","family":"Saherwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnma.2022.09.003_bib0001","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2019.02.018","article-title":"Sickle Cell Disease and Stroke","volume":"95","author":"Hirtz","year":"2019","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.jnma.2022.09.003_bib0002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/asheducation-2016.1.640","article-title":"Sicle Cell Disease: An Inherited Thrombophilia","author":"Wun","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.jnma.2022.09.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019001142","article-title":"ASH 2020 guidelines for sickle cell disease: prevention, diagnosis and treatment of cerebrovascular disease in children and adults","author":"DeBaun","year":"2020","journal-title":"Blood advances"},{"key":"10.1016\/j.jnma.2022.09.003_bib0004","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempng","year":"1998","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.jnma.2022.09.003_bib0005","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1182\/blood-2009-05-220921","article-title":"Sickle Cell Disease and Stroke","volume":"114","author":"Verduzco","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jnma.2022.09.003_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220011","article-title":"Thrombolytic therapy for the treatment of acute ischemic stroke in adults with homozygous sickle cell disease","author":"Majhadi","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jnma.2022.09.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28499","article-title":"Hemoglobin A1c and fructosamine correlate in a patient with sickle cell disease and diabetes on chronic transfusion therapy","author":"McLean","year":"2020","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.jnma.2022.09.003_bib0008","series-title":"Sudden Onset Blindness in Sickle Cell Disease Due to Retinal Artery Occlusion","author":"Liem","year":"2007"},{"key":"10.1016\/j.jnma.2022.09.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019001142","article-title":"ASH 2020 guidelines for sickle cell disease: prevention, diagnosis and treatment of cerebrovascular disease in children and adults","author":"DeBaun","year":"2020","journal-title":"Blood advances"},{"key":"10.1016\/j.jnma.2022.09.003_bib0010","unstructured":"Ibid."},{"key":"10.1016\/j.jnma.2022.09.003_bib0011","article-title":"Management of Central Retinal Artery Occlusion: A Scientific Statement from the AHA","volume":"52","author":"Grory","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jnma.2022.09.003_bib0012","unstructured":"Chua M, Giovinazzo J, Kaplan R, et al. Paracentral Acute Middle Maculopathy as a Presenting Sign of CRAO in Sickle Cell Disease Treated with Tissue Plasminogen Activator. Retinal Cases & Brief Reports Publish Ahead of Print. DOI 10.1097"},{"key":"10.1016\/j.jnma.2022.09.003_bib0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","article-title":"tPA Mobilizes Immune Cells that Exacerbate Hemorrhagic Transformation in Stroke","volume":"128","author":"Shi","year":"2021","journal-title":"Circulation Research"},{"key":"10.1016\/j.jnma.2022.09.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.116.015412","article-title":"Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke","author":"Adams","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jnma.2022.09.003_bib0015","unstructured":"ibid"},{"key":"10.1016\/j.jnma.2022.09.003_bib0016","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1161\/STROKEAHA.117.018334","article-title":"Sickle Mice Are Sensitive to Hypoxia\/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment","volume":"48","author":"Sun","year":"2017","journal-title":"Stroke"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:20:04Z","timestamp":1758435604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968422001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0027968422001560"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2022.09.003","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic thrombolysis for acute central retinal artery occlusion in sickle cell disease: Case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of National Medical Association.","name":"copyright","label":"Copyright"}]}}